Medical Oncology

Dendritic cells highly quoted on immunotherapy stock market
pp. 195-196(2)
Author: Masucci, Giuseppe

Gene-modified dendritic cells for immunotherapy against cancer
pp. 197-211(15)
Authors: Lundqvist, Andreas; Pisa, Pavel

Dendritic cell vaccines in the treatment of multiple myeloma: Advances and limitations
pp. 213-218(6)
Authors: Büchler, Tomas; Hajek, Roman

Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma
pp. 219-226(8)
Authors: Srkalovic, Gordan; Elson, Paul; Trebisky, Beth; Karam, Mary; Hussein, Mohamad

Oral ftorafur plus intramuscular thiotepa as adjuvant chemotherapy in patients with breast cancer
pp. 227-232(6)
Authors: Galmarini, C.; Garbovesky, C.; Galmarini, D.; Galmarini, F.

Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: A series of 308 cases
pp. 233-237(5)
Authors: Ganti, Apar; Potti, Anil; Koch, Michael; Tendulkar, Ketki; Hanekom, David; Koka, Vijay; Levitt, Ralph

Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer
pp. 239-248(10)
Authors: Terada, Ryusuke; Yasutake, Toru; Nakamura, Shirou; Hisamatsu, Takashi; Sawai, Terumitsu; Yamaguchi, Hiroyuki; Nakagoe, Tohru; Ayabe, Hiroyoshi; Tagawa, Yutaka

Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes
pp. 249-259(11)
Authors: Marisavljević, D.; Rolović, Z.; Šefer, D.; Basara, N.; Ilić, D.; Bošković, D.; Čolović, M.

Pharmacokinetics of oxaliplatin in humans
pp. 261-265(5)
Authors: Ehrsson, H.; Wallin, I.; Yachnin, J.

A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes
pp. 267-272(6)
Authors: Mathur, P.; Chaudhry, R.; Kumar, L.; Kapil, A.; Dhawan, B.

Pancreatic metastasis and extrahepatic biliary obstruction in squamous cell lung carcinoma
pp. 273-276(4)
Authors: Moazzam, Nauman; Ali, Mir; Potti, Anil

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia
pp. 277-280(4)
Authors: Cavalli-Björkman, Nina; Ösby, Eva; Lundin, Jeanette; Kalin, Mats; Österborg, Anders; Gruber, Astrid